Triazabenzo[e]azulene derivatives for the treatment of tumors

Details for Australian Patent Application No. 2007315374 (hide)

Owner Merck Patent GmbH

Inventors Amendt, Christiane; Hoelzemann, Guenter; Greiner, Hartmut

Agent Davies Collison Cave

Pub. Number AU-B-2007315374

PCT Pub. Number WO2008/052628

Priority 10 2006 051 796.2 03.11.06 DE

Filing date 29 September 2007

Wipo publication date 8 May 2008

Acceptance publication date 26 July 2012

International Classifications

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 35/00 Antineoplastic agents

Event Publications

25 June 2009 PCT application entered the National Phase

  PCT publication WO2008/052628 Priority application(s): WO2008/052628

9 July 2009 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Merck Patent GmbH, Application No. 2007315374, under INID (54) correct the title to read Triazabenzo[e]azulene derivatives for the treatment of tumors

26 July 2012 Application Accepted

  Published as AU-B-2007315374

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007315380-Infusion set

2007315373-Device and method for postprocessing spectral values and encoder and decoder for audio signals